We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Net Loss -- $7.5 million, translating to negative $0.38 per share, with an operating loss of $7 million, improved from a ...
Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback